New Key Statistics Module, Z-Score and F-Score
TSXV:LSL Key Ratios
Market Cap C$ M | 54.00 |
Enterprise Value C$ M | 70.26 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.67 |
Price/Sales | 3.89 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 10.00 |
EPS (TTM) C$ | -0.12 |
Beneish M-Score | -2.8 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -10.43 |
EV-to-EBITDA | -12.53 |
PEG | -- |
Shares Outstanding M | 108.01 |
Net Margin (%) | -84.47 |
Operating Margin % | -39.43 |
Pre-tax Margin (%) | -84.47 |
Quick Ratio | 0.21 |
Current Ratio | 0.48 |
ROA % (ttm) | -28.93 |
ROE % (ttm) | -92.37 |
ROIC % (ttm) | -13.72 |
Dividend Yield % | -- |
Altman Z-Score | -0.10 |
TSXV:LSL Number of Guru Trades
TSXV:LSL Volume of Guru Trades
Gurus Latest Trades with TSXV:LSL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:LSL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
LSL Pharma Group Inc Insider Transactions
No Available Data